MEBAAL Tablet
ក្រុមហ៊ុនផលិតឱសថ:
WINDLAS BIOTECH LIMITED, India
ក្រុមហ៊ុនចែកចាយឱសថនៅប្រទេសកម្ពុជា:
MEGA We care
- សារធាតុសកម្ម
- ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់
- ហាមប្រើ
- ផលរំខាន
- អន្តរប្រតិកម្ម
- ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន
- សកម្មភាពឱសថ បរិយាយប័ណ្ណឱសថ
-
សារធាតុសកម្ម
1. MEBAAL-500:
Methycobalamin 500mg
2. MEBAAL-1500:
Methycobalamin 1500mg
-
ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់
Peripheral neuropathies like diabetic neuropathy, alcoholic neuropathy, drug induced neuropathy, trigeminal & occupational neuralgia, bells palsy and Megaloblastic anemia.
Dose
Usually for adults, orally administer 1 tab 3 times daily or 1 tab OD.
The dosage should be adjusted according to age of patient and severity of symptoms.
-
ហាមប្រើ
Hypersensitivity to Methylcobalamin.
-
ផលរំខាន
Anaphylactic reaction: anaphylactic reaction such as decrease in blood pressure or dyspnea may occur. Patient should be monitored after administration of dose.
-
អន្តរប្រតិកម្ម
See the package insert about the details below:
- Antibiotics
- Cholestyramine
- Colchicine
- Colestipol
- H2 blockers (cimetidine, famotidine, nizatidine, ranitidine)
- Metformin
- Nitrous oxide
- Para-amino salicylic acid
- Potassium chloride
- PPI (lansoprazole, omeprazole, pantoprazole, rabeprazole)
-
ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន
The use of Methylcobalamin in deficiency states or to treat any medical condition requires medical supervision. A typical dose as nutritional supplements used by pregnant women and nursing mothers is 12 mcg daily. Pregnant women and nursing mothers should only use doses higher than this if recommended by their physicians. Administration of doses greater than 10mcg daily may produce a hematological response in those with anemia secondary to folate deficiency.
-
សកម្មភាពឱសថ
Methylcobalamin is one of the two active coenzyme forms of vitamin B-12. It is a co-factor to the enzyme methionine synthetase that function to transfer methyl groups for the regeneration of methionine from homocysteine. It is closely involved in folate metabolism, and is pivotal for the synthesis of purines and pyrimidines. It also acts as a methyl donor for the synthesis of lecithin, a major component of myelin sheath.
l Methylcobalamin pays an important role in transmethylation as a coenzyme of methionine synthetase in synthesis of methionine from homocysteine.
l Methylcobalamin is well transported to nerve cell organelles, and promotes nucleic acid and protein synthesis. It is better transported to nerve cell organelles than cyanocobalamin in animals.
l Methylcobalamin promotes axonal regeneration. It normalizes axonal skeletal protein transport in sciatic nerve cells from animal’s models with streptozotocin induced diabetes mellitus. It exhibits neuropathologically and electrophysiologically inhibitory effects on nerve degeneration in neuropathies induced by drugs, such as adriamycin, acrylamide, and vincristine models of axonal degeneration in mice and neuropathies in animals with spontaneous diabetes mellitus.
l Methylcobalamin promotes myelination (phospholipid synthesis). It promotes the synthesis of lecithin, the main constituent of medullary sheath lipid and increases myelination of neurons in animal tissue culture more than cobalamide does.
l Methylcobalamin restores delayed synaptic transmission and diminished neurotransmitters to normal. It restores and plate potential induction early by increasing nerve fiber excitability in crushed sciatic nerve. In addition, it also normalizes diminished brain tissue levels of acetylcholine in animals fed a choline-deficient diet.
l Methylcobalamin promotes the maturation and division of erythroblasts, thereby alleviating anemia. It also promotes nucleic acid synthesis in bone marrow and promotes the maturation and division of erythroblasts, thereby increasing erythrocyte production.
l Methylcobalamin brings about a rapid recovery of diminished red blood cell, hemoglobin, and hematocrit in vitamin B-12 deficient animals.
*ព័ត៌មានឱសថត្រូវបានរៀបរៀងដោយ អ៊ីម៉ាតុគឹ មេឌីក (ខេមបូឌា) ដោយផ្អែកលើប្រភពព័ត៌មានខាងក្រោម។ សម្រាប់ព័ត៌មានលម្អិត សូមស្វែងរកនៅក្នុងក្រដាសព័ត៌មាននៃឱសថនីមួយៗ ឬ សាកសួរទៅកាន់ក្រុមហ៊ុនឱសថឬតំណាងចែកចាយនៃឱសថនីមួយៗ។
ប្រភពព័ត៌មាន៖
- ក្រដាសព័ត៌មាននៃឱសថសម្រាប់អ្នកជំនាញវេជ្ជសាស្ត្រដែលប្រើប្រាស់នៅប្រទេសជប៉ុន (Pharmaceutical and Medical Devices Agency, Pmda): https://www.pmda.go.jp
- ព័ត៌មានសង្ខេបនៃឱសថសម្រាប់អ្នកជំងឺដែលប្រើប្រាស់នៅប្រទេសជប៉ុន: http://www.rad-ar.or.jp